Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
暂无分享,去创建一个
U. Capitanio | F. Montorsi | Y. Lotan | V. Margulis | A. Sagalowsky | R. Ashfaq | G. Netto | S. Shariat | P. Karakiewicz | S. Lerner | M. Nielsen | S. Müller | P. Bastian | L. Heukamp | Y. Fradet | J. Rigaud
[1] F. Montorsi,et al. Predicting survival after radical cystectomy for bladder cancer , 2008, BJU international.
[2] R. Gelber,et al. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. , 2008, Journal of the National Cancer Institute.
[3] Yair Lotan,et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy , 2008, Cancer.
[4] Wun-Jae Kim. Multiple biomarkers improve prediction of bladder cancer progression and cancer specific survival , 2008 .
[5] P. Carroll,et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. , 2007, The Journal of urology.
[6] Y. Lotan,et al. Ki-67 Is an Independent Predictor of Bladder Cancer Outcome in Patients Treated with Radical Cystectomy for Organ-Confined Disease , 2006, Clinical Cancer Research.
[7] Yair Lotan,et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.
[8] Y. Noguchi,et al. Growth index, assessed with Ki‐67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma , 2005, Journal of surgical oncology.
[9] E. Messing,et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. , 2005, Urology.
[10] D. Elder,et al. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Grignon,et al. Ki-67 Staining Index Predicts Distant Metastasis and Survival in Locally Advanced Prostate Cancer Treated With Radiotherapy , 2004, Clinical Cancer Research.
[12] C. Vale. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis , 2003, The Lancet.
[13] Michael W Kattan,et al. Judging new markers by their ability to improve predictive accuracy. , 2003, Journal of the National Cancer Institute.
[14] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[15] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] A. Hoznek,et al. The prognostic value of p53 nuclear overexpression and MIB‐1 as a proliferative marker in transitional cell carcinoma of the bladder , 1997, Cancer.
[17] Y. Takano,et al. Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy. , 1997, Pathology, research and practice.
[18] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[19] F. Freiha,et al. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. , 1996, Journal of Urology.
[20] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[21] Johannes Gerdes,et al. Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.
[22] M. Stöckle,et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. , 1992, The Journal of urology.
[23] W. H. Kern,et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. , 1991, The Journal of urology.
[24] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.